To evaluate the in-vivo efficacy and safety of hair care formulation in terms of reduction in hair fall effect on human subjects - NI

BEAUTY GARAGE INDIA PVT. LTD.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Asian Indian humans subjects.
•2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable
•and stop the study, no pathology which could interfere with the study, no symptom in the process
•of an exploratory checkup)
•3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
•4.Having oily scalp and moderate to severe hair fall

•1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
•2.Having refused to give his/her assent by not signing the consent form.
•3.Taking part in another study liable to interfere with this study.
•4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area.
•5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less
•than 6 months)
•6.Having a progressive asthma (either under treatment or last fit in the last 2 years)
•7.Being epileptic
•8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6
•9.Having cutaneous hypersensitivity
•10.Following a chronic or intermittent medicinal treatment comprising any of the following products
•: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy,
•taken by general or local routes (the only medication permitted is paracetamol)
•11.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6
•12.Having changed her cosmetic habits except those mentioned in protocol in the 7 days preceding
•the start of the study on the studied anatomic unit

发起方

BEAUTY GARAGE INDIA PVT. LTD.